secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2026-06-05T20:00:16+00:00
Accession:  0001411690-26-000036
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics CMO Alka Chaubey resigns effective July 5, 2026
----------------------------------------------------------------

- Alka Chaubey, Ph.D. resigned as Chief Medical Officer on June 2, 2026.
- Her resignation becomes effective July 5, 2026.
- No replacement or reason for departure was disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000036/0001411690-26-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000036/bngo-20260602.htm
  HTML page:      https://secwatch.observer/filing/0001411690-26-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer